Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus pre-PCI tirofiban in high-risk NSTE-ACS patients undergoing PCI
ChiCTR-TRC-10000777Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tirofiban in acute coronary syndrome (ACS) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Thrombolysis in Myocardial Blush grade. Started Mar 2010; status: completed.
02
Drugs
tirofiban
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR-TRC-10000777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000777.